# Rho D Immune Globulin

## Rho (D) Immune Globulin [HyperRHO] 專案進口

| TAH Drug Code      | [IRHO1](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IRHO1)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Antepartum and postpartum RhD prophylaxis for the prevention of hemolytic disease of the newborn; RhD prophylaxis following spontaneous or induced abortion, ruptured tubal pregnancy, amniocentesis or abdominal trauma.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Dosing             | Routine antepartum prophylaxis: IM 300 mcg; give at 26-28 weeks gestation; if given early in pregnancy (before 26-28 weeks gestation), repeat dose at 12-week intervals to maintain adequate protection. Postpartum prophylaxis: if newborn is Rh-positive: IM 300 mcg; administer as soon as possible and within 72 hours after delivery. Abortion, miscarriage, or termination of ectopic pregnancy (13 weeks gestation or greater): IM 300 mcg; administer within 72 hours. Amniocentesis or chorionic villus sampling: IM 300 mcg; administer within 72 hours of procedure; if dose given between 13 and 18 weeks gestation, repeat dose at 26-28 weeks. Abdominal trauma or manipulation: IM 300 mcg; administer within 72 hours after complication/procedure; if dose given between 13 and 18 weeks gestation, repeat dose at 26 to 28 weeks and within 72 hours of delivery. Threatened abortion with continuation of pregnancy: IM 300 mcg. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Contraindications  | Known anaphylaxis or severe hypersensitivity reaction to human immune globulin products. Patients with a history of autoimmune hemolytic anemia, pre-existing hemolysis, or who are at high risk for hemolysis. IgA deficiency with antibodies against IgA. Infants for the suppression of Rh isoimmunization.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Adverse Effects    | Common: Injection site pain (0.5%), Nausea (0.7%), Extravascular hemolysis (Mild) (21%), Hemoglobin below reference range, Dizziness (0.5%), Headache (0.5-14.3%), Malaise (0.5%) Serious: Intravascular hemolysis, Anaphylaxis (rare), Renal failure, acute                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |

